Key Factor Supporting Psychedelic Drugs Market Development in 2025: Surging Cases Of Mental Illness To Drive Market Growth

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Psychedelic Drugs Market Size By 2025?
In recent times, the size of the psychedelic drugs market has experienced swift growth. Its expansion is projected to continue, rising from $5.56 billion in 2024 to an estimated $6.33 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 13.9%. The growth observed in the past can be attributed to changes in the regulatory landscape, heightened awareness of mental health, and shifts in public opinion.

How Big Is the Psychedelic Drugs Market Size Expected to Grow by 2029?
The market size of psychedelic drugs is projected to experience a substantial increase in the coming years, with estimations showing that the value will reach "$11.68 billion in 2029" at a Compound Annual Growth Rate (CAGR) of "16.5%". This projected expansion during the forecasted period can be ascribed to factors such as advancements in the development of these drugs, expanding use in therapeutic applications, increasing acceptance within the medical community, shifts in public policy, and the management of mental health crises. Future trends during this projected period will likely focus on enhancing public awareness and education, changes in legal and regulatory standards, diversification of psychedelic substances, and a shift towards more patient-centric treatment methods.

View the full report here:
https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

Which Key Market Drivers Powering Psychedelic Drugs Market Expansion and Growth?
The rise in mental health disorders is anticipated to drive the expansion of the psychedelic drugs market in the future. Mental health disorders are health issues that involve alterations in emotions, cognition, or behavior. These conditions include distress and post-traumatic stress disorder (PTSD). Psychedelic drugs, which are used to alleviate depression and PTSD, can reduce the occurrences of these mental health disorders through regular use. For example, the National Centre for Social Research, a UK-based social research institute, reported in November 2022 that the percentage of 17 to 19 year olds with potential mental health issues increased from 17.4% in 2021 to 25.7% in 2022. With the increasing rate of such mental health disorders, the growth of the psychedelic drugs market is set to be positively impacted.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

What Long-Term Trends Will Define the Future of the Psychedelic Drugs Market?
Key players in the psychedelic drugs market, such as ketamine, are pushing the boundaries of innovation to enhance therapeutic results for mental health disorders, increase patient's access to their treatments, and unveil new uses of psychedelic substances in treating depression, anxiety, PTSD, and substance use disorders. Ketamine is a type of anesthetic and painkiller known for its dissociative effects and is being investigated for its quick-acting antidepressant impact on severe depression and PTSD. In a significant development, in March 2022, Husch Blackwell, an established US company, rolled out the Psychedelics and Emerging Therapies Practice Group. This practice group aims to support innovators in researching, developing, and bringing to market groundbreaking therapies derived from psychedelics. It is made up of a multi-disciplinary team of lawyers skilled in understanding and navigating the complex laws surrounding these psychoactive substances, often classified as Schedule I controlled substances under U.S. federal law. This categorization imposes substantial regulatory obstacles that can impede research and development ambitions.

What Are the Emerging Segments in the Psychedelic Drugs Market?
The psychedelic drugs market covered in this report is segmented -

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia
2) By Disease Indication: Depression, PTSD
3) By Origin: Natural, Synthetic
4) By Application: Treatment-Resistant Depression, Opi*ate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders
5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:
1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters
2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable
3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid
4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules
5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6345&type=smp

Who Are the Global Leaders in the Psychedelic Drugs Market?
Major companies operating in the psychedelic drugs market include Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, Universal Ibogaine

Which are the Top Profitable Regional Markets for the Psychedelic Drugs Industry?
North America was the largest region in the psychedelic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6345

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.